Inovio Pharma (INO) Stock Price, Quote & News

Company Profile

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline inclu...

Industry: Biotechnology

Sector: Healthcare

Phone: 267 440 4200

Website: www.inovio.com

Address:

660 West Germantown Pike, Suite 110, Plymouth Meeting, United States

AtomicAIerts Dec. 5 at 12:40 PM

$INO AtomicAlerts Scalp Alert Direction: SHORT Entry: $2.02 TP1: $1.32 | TP2: $0.62 | TP3: $-0.08 Stop Loss: $2.62 👉 https://atomicalerts.com

0 · Reply

User32548888 Dec. 5 at 11:39 AM

$INO phew... I need it pump 20000% to have every share of mine back to green. SMH....

0 · Reply

Iightning Dec. 5 at 6:47 AM

1ightning® Premium Options Alert (Actionable) Ticker: $INO Contract: Dec 19 $1.5C Entry: 0.60 Exit: 1.04 Return: +73.78% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Iightning Dec. 5 at 12:36 AM

1ightning® Premium Options Alert (Actionable) Ticker: $INO Contract: Dec 19 $1.5C Entry: 0.60 Exit: 1.04 Return: +73.78% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Jrtreats Dec. 4 at 11:58 PM

$INO 10 second Cellectra injection/electraportion of INO-3107 that's room temp stable administered in any doctor's office or this precigen mess. dosing-and-administration-guide.pdf https://share.google/FRKuoj37vC3M0QqiE I think it's a super easy decision for both patients and doctors with this alone. Very very

3 · Reply

GorillaofWallStreet Dec. 4 at 11:47 PM

$INO Is that you Dr Kimmy? Was it really necessary to take that 6 mil before you left?

0 · Reply

INOVIO Dec. 4 at 10:18 PM

$INO Just wrapped a couple meetings and everything is looking promising and right on track. The short punishment is coming… and it’s coming soon! Hang tight, our moment is around the corner!

0 · Reply

kenbkb Dec. 4 at 8:55 PM

$INO So, have not been here awhile, what's the latest? Another ten years before any molecule approval?

0 · Reply

RajCx Dec. 4 at 7:34 PM

$INO https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:2426813:0-ino-ino-3107-shows-strong-efficacy-and-safety-in-rrp-with-launch-preparations-underway-for-2025/

0 · Reply

WrongRioe Dec. 4 at 7:25 PM

$INO hahaha, and this turd turns red when all dog shi* biotech companies are up 3% or more

0 · Reply

Inovio Pharmaceuticals, Inc. (INO) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Nov 18, 2025, 8:05 AM EST - 16 days ago

INOVIO to Participate in December Investor Conferences

Nov 12, 2025, 9:53 AM EST - 22 days ago

Inovio 3Q25 Review: EPS Miss, $25M Offering, And INO-3107 Progress

Nov 11, 2025, 8:40 AM EST - 23 days ago

INOVIO Announces Pricing of $25 Million Public Offering

Nov 10, 2025, 7:31 PM EST - 24 days ago

Inovio Pharmaceuticals, Inc. (INO) Q3 2025 Earnings Call Transcript

Nov 10, 2025, 6:09 PM EST - 24 days ago

INOVIO Announces Proposed Public Offering

Nov 10, 2025, 4:05 PM EST - 24 days ago

INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Nov 3, 2025, 8:05 AM EST - 4 weeks ago

INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

Oct 31, 2025, 4:53 PM EDT - 4 weeks ago

INOVIO Reports Inducement Grant Under Inducement Plan

Oct 27, 2025, 8:05 AM EDT - 5 weeks ago

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025

Oct 23, 2025, 4:05 PM EDT - 6 weeks ago

INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference

Oct 21, 2025, 8:05 AM EDT - 6 weeks ago

Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine

Sep 25, 2025, 8:05 AM EDT - 2 months ago

INOVIO to Participate in Upcoming Scientific Conferences

Sep 5, 2025, 9:37 AM EDT - 3 months ago

Inovio Pharmaceuticals, Inc. (INO) Presents At H.C. Wainwright 27th Annual Global Investment Conference (Transcript)

Aug 26, 2025, 8:05 AM EDT - 3 months ago

INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults

Aug 25, 2025, 8:05 AM EDT - 3 months ago

INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Aug 13, 2025, 3:26 AM EDT - 4 months ago

Inovio Pharmaceuticals, Inc. (INO) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 4:05 PM EDT - 4 months ago

INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Aug 11, 2025, 8:05 AM EDT - 4 months ago

Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)

Aug 4, 2025, 4:05 PM EDT - 4 months ago

INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025

Jul 7, 2025, 4:05 PM EDT - 5 months ago

INOVIO to Present at Upcoming Scientific Conference

Jul 1, 2025, 7:00 AM EDT - 5 months ago

Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development

May 13, 2025, 7:05 PM EDT - 7 months ago

Inovio Pharmaceuticals, Inc. (INO) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:05 PM EDT - 7 months ago

INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights

May 9, 2025, 7:37 PM EDT - 7 months ago

Inovio Pharmaceuticals, Inc. (INO) Citizens JMP Life Sciences Conference (Transcript)

Apr 30, 2025, 8:05 AM EDT - 7 months ago

INOVIO to Present at Upcoming Scientific and Investor Conferences

Apr 29, 2025, 8:05 AM EDT - 7 months ago

INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025

Apr 9, 2025, 8:05 AM EDT - 8 months ago

INOVIO to Present at Upcoming Scientific Conferences

Mar 18, 2025, 8:48 PM EDT - 9 months ago

Inovio Pharmaceuticals, Inc. (INO) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 4:05 PM EDT - 9 months ago

INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Mar 13, 2025, 6:15 PM EDT - 9 months ago

INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19

Mar 12, 2025, 12:55 PM EDT - 9 months ago

INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025

Feb 12, 2025, 5:39 PM EST - 10 months ago

Inovio Pharmaceuticals Inc (INO) Oppenheimer 35th Annual Healthcare Life Sciences Conference (Transcript)

Feb 12, 2025, 8:00 AM EST - 10 months ago

Clinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications

Feb 10, 2025, 8:05 AM EST - 10 months ago

Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference

Jan 29, 2025, 4:14 PM EST - 11 months ago

INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Jan 9, 2025, 8:04 AM EST - 11 months ago

INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments

Jan 6, 2025, 7:19 AM EST - 11 months ago

Top 3 Health Care Stocks That Could Blast Off This Month

OTLK RCKT

Dec 13, 2024, 2:10 PM EST - 1 year ago

Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet

Dec 13, 2024, 7:00 AM EST - 1 year ago

INOVIO Announces Pricing of $30 Million Public Offering

Dec 3, 2024, 8:00 AM EST - 1 year ago

New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial

Nov 15, 2024, 11:21 AM EST - 1 year ago

European And US Vaccine Stocks Are Under Pressure - Here's WHy

AZN BNTX GSK MRK SNY VALN

Nov 14, 2024, 7:53 PM EST - 1 year ago

Inovio Pharmaceuticals, Inc. (INO) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 4:05 PM EST - 1 year ago

INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 13, 2024, 8:00 AM EST - 1 year ago

Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial

Nov 6, 2024, 8:00 AM EST - 1 year ago

INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024

Oct 21, 2024, 8:00 AM EDT - 1 year ago

INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP

Oct 2, 2024, 4:15 PM EDT - 1 year ago

INOVIO Reports Inducement Grants Under Inducement Plan

Aug 9, 2024, 3:32 AM EDT - 1 year ago

Inovio Pharmaceuticals, Inc. (INO) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:05 PM EDT - 1 year ago

INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights

AtomicAIerts Dec. 5 at 12:40 PM

$INO AtomicAlerts Scalp Alert Direction: SHORT Entry: $2.02 TP1: $1.32 | TP2: $0.62 | TP3: $-0.08 Stop Loss: $2.62 👉 https://atomicalerts.com

0 · Reply

User32548888 Dec. 5 at 11:39 AM

$INO phew... I need it pump 20000% to have every share of mine back to green. SMH....

0 · Reply

Iightning Dec. 5 at 6:47 AM

1ightning® Premium Options Alert (Actionable) Ticker: $INO Contract: Dec 19 $1.5C Entry: 0.60 Exit: 1.04 Return: +73.78% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Iightning Dec. 5 at 12:36 AM

1ightning® Premium Options Alert (Actionable) Ticker: $INO Contract: Dec 19 $1.5C Entry: 0.60 Exit: 1.04 Return: +73.78% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Jrtreats Dec. 4 at 11:58 PM

3 · Reply

GorillaofWallStreet Dec. 4 at 11:47 PM

$INO Is that you Dr Kimmy? Was it really necessary to take that 6 mil before you left?

0 · Reply

INOVIO Dec. 4 at 10:18 PM

$INO Just wrapped a couple meetings and everything is looking promising and right on track. The short punishment is coming… and it’s coming soon! Hang tight, our moment is around the corner!

0 · Reply

kenbkb Dec. 4 at 8:55 PM

$INO So, have not been here awhile, what's the latest? Another ten years before any molecule approval?

0 · Reply

RajCx Dec. 4 at 7:34 PM

$INO https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:2426813:0-ino-ino-3107-shows-strong-efficacy-and-safety-in-rrp-with-launch-preparations-underway-for-2025/

0 · Reply

WrongRioe Dec. 4 at 7:25 PM

$INO hahaha, and this turd turns red when all dog shi* biotech companies are up 3% or more

0 · Reply

Lookingdown Dec. 4 at 6:32 PM

$INO

1 · Reply

Inoboatguy Dec. 4 at 6:31 PM

$INO very

1 · Reply

GorillaofWallStreet Dec. 4 at 2:39 PM

$INO Life is good when all the pumpers have blocked me.

1 · Reply

Iightning Dec. 4 at 8:13 AM

1ightning® Premium Options Alert (Actionable) Ticker: $INO Contract: Dec 19 $1.5C Entry: 0.57 Exit: 0.94 Return: +63.90% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

HedgeAlerts Dec. 4 at 6:37 AM

Hedge Alert Live - Protect Your Portfolio Contract: $INO $2.00 Put · DEC 12, 2025 Exp Entry Price: $0.15 - $0.20 Exit Price Target: $0.31 Profit Margin: +108% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com

0 · Reply

LiquidThetaOptions Dec. 4 at 4:49 AM

💎 LiquidTheta® Live Actionable Trade Asset: $INO Contracts: $INO May 15, 2026 $3 Calls Scale in: $0.20- $0.25 Scale out: $0.79-$1.35 Profit Potential : 122% ROI Blended Join 💎 Here: https://liquidtheta.com

0 · Reply

MarcoFla99 Dec. 4 at 3:12 AM

$INO https://www.expertmarketresearch.com/healthcare-articles/top-hpv-vaccine-companies

1 · Reply

BewareRioeThePumper Dec. 4 at 2:26 AM

$INO hahahaha. I’ve heard it all now on this board. Such delusions. Marco, none of those companies have dna based medicines. There is a reason why no dna medicine has ever been approved. As for selling the company. That’s laughable. Go lookup how much stock insiders of this company own. And ask yourself if they’re aligned with shareholders or just want to continue collecting their salaries, dilution be damned

1 · Reply

MarcoFla99 Dec. 4 at 2:11 AM

$INO The largest companies involved in DNA-based or DNA-related treatments for HPV include Merck and GlaxoSmithKline (GSK), known for their HPV vaccines like Gardasil and Cervarix, respectively. INOVIO Pharmaceuticals is a leading company developing DNA medicines for HPV-associated diseases. Other significant players in the broader HPV market include Roche, which provides DNA testing for HPV, and other companies with candidates in development, such as Gilead Sciences and BioNTech. Why doesn't SHEA sell the company? I'm sure we could fetch a billion?

3 · Reply

BewareRioeThePumper Dec. 3 at 11:28 PM

$INO hey Luis, stick to TA bro. Sheas ugly ass mentions partnerships at least annually that never materialize. Clowns like you think it will happen cause you breathe in her hopium. Losing 25k will do that to ya I guess. Glad to see you’re back to losing more money on this trash can of a company. Easiest short ever. There still resistance at 0?😂

1 · Reply

BewareRioeThePumper Dec. 3 at 11:24 PM

$INO you da man LD!🫢

0 · Reply

BentleyT99 Dec. 3 at 10:49 PM

$INO Multiple Partnerships Coming Soon....INOVIO Is In Talks With Potential Partners $$$$$$$$$$$

0 · Reply

Market Cap	134.80M
Revenue (ttm)	220,000.00
Net Income (ttm)	-107.25M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-48,750.00%
Debt to Equity Ratio	0.00

Volume	679,800
Avg Vol	1,126,238
Day's Range	N/A - N/A
Shares Out	66.73M
Stochastic %K	80%
Beta	1.54
Analysts	Strong Sell
Price Target	$7.63